HYBRID Coating 10-Q/A 20 Nov 14 2014 Q3 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 14, 2014
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Trading Symbol	'hcti	'
Entity Registrant Name	'HYBRID Coating Technologies Inc.	'
Entity Central Index Key	'0001445235	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	21,529,594
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well Known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current assets	'	'
Cash	$2,056	$0
Prepaid rent	11,250	0
TOTAL CURRENT ASSETS	13,306	0
Intangible asset, net of accumulated amortization	735,085	444,940
TOTAL ASSETS	748,391	444,940
Current liabilities	'	'
Bank indebtedness	0	7,706
Accounts payable and accrued liabilities	545,240	564,289
Accounts payable and accrued liabilities-related parties	381,351	491,178
Deferred revenue	20,000	20,000
Stock payable	15,000	15,000
Senior secured convertible debentures	200,000	200,000
Convertible notes payable, net of unamortized discount of $93,637 and $0, respectively	17,474	0
Loans payable net of unamortized discount of $0 and $5,455, respectively	977,500	972,045
Loans payable - shareholders, net of unamortized discounts and premiums of $0 and $21,890, respectively	1,842,991	1,343,562
Note payable - related party	36,291	682,451
Total current liabilities	4,035,847	4,296,231
Convertible debentures	1,320,500	1,396,858
Derivative liabilities	192,505	816,488
Total liabilities	5,548,852	6,509,577
Commitments and contingencies	0	0
STOCKHOLDERS' DEFICIT	'	'
Common stock, $0.001 par value, 75,000,000 shares authorized, 39,271,829 shares and 11,167,513 shares issued and outstanding, respectively	39,272	11,168
Additional paid-in capital	15,871,488	10,712,971
Accumulated deficit	-20,711,221	-16,788,776
Total stockholders' deficit	-4,800,461	-6,064,637
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$748,391	$444,940

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Convertible notes payable, net of unamortized discount	$93,637	$0
Loans payable - unamortized discount	0	5,455
Loans payable - shareholders - unamortized discounts and premiums	$0	$21,890
Common Stock, Par Value Per Share	$0.00	$0.00
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares, Issued	39,271,829	11,167,513
Common Stock, Shares, Outstanding	39,271,829	11,167,513

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues	$0	$48,483	$29,370	$56,631
Cost of sales	0	22,312	1,994	25,979
Gross margin	0	26,171	27,376	30,652
Operating expenses	'	'	'	'
General and administrative	729,288	591,851	2,033,685	1,903,852
Amortization of intangible asset	137,075	36,390	209,855	145,633
Total operating expenses	866,363	628,241	2,243,540	2,049,485
Loss from operations	-866,363	-602,070	-2,216,164	-2,018,833
Warrant modification expense	0	0	0	-241,697
Loss on extinguishment of debt	-627,329	-22,000	-1,967,408	-315,791
Change in fair value of derivative liabilities	14,777	11,537	777,685	47,442
Gain (loss) on foreign currency translation	603	0	-925	0
Interest expense	-230,856	-208,304	-515,633	-637,672
Net loss	($1,709,168)	($820,837)	($3,922,445)	($3,166,551)
Basic and diluted net loss per common share	($0.07)	($0.09)	($0.22)	($0.41)
Basic and diluted weighted average number of common shares outstanding	24,279,061	8,786,457	17,601,644	7,785,062

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net loss	($3,922,445)	($3,166,551)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Stock-based compensation	1,136,385	1,062,703
Warrant modification expense	0	241,697
Interest paid through issuance of shares	23,255	8,828
Interest expense on derivative liability that exceeds face value of debt	53,702	0
Amortization of intangible asset	209,855	145,633
Loss on extinguishment of debt	1,967,408	315,791
Change in fair value of derivative liability	-777,685	-47,442
Interest imputed from notes payable -related party	96,000	101,776
Amortization of debt discounts	44,910	240,538
Loss on foreign currency translation	3,034	-1,572
Change in operating assets and liabilities	'	'
Accounts payable and accrued liabilities	220,013	220,507
Accounts payable and accrued liabilities - related parties	648,549	476,604
Bank overdraft	-7,706	0
Net cash used in operating activities	-304,725	-401,488
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Proceeds from exercise of warrants	300	0
Proceeds from convertible notes	100,000	0
Proceeds from loans payable-shareholders	906,671	562,648
Repayments from loans payable-shareholders	-426,190	-335,630
Proceeds from loans payable	0	260,000
Repayments of note payable - related party	-274,000	-85,530
Net cash provided by financing activities	306,781	401,488
INCREASE (DECREASE) IN CASH	2,056	0
CASH, BEGINNING	0	0
CASH, ENDING	2,056	0
Cash paid during the period for:	'	'
Interest paid	34,162	85,725
Income taxes	0	0
Non-cash financing transactions:	'	'
Reclassification of bank overdrafts to payables	0	16,266
Discount arising from loans payable -shareholders	0	9,148
Discount arising from loans payable	0	23,705
Common stock issued for prepaid expenses	11,250	0
Reclassification of note payable to accounts payable	0	11,600
Common stock issued for acquisition of intangible assets	500,000	0
Common stock issued for accounts payable	92,590	0
Common stock issued for interest accrued	32,603	180,857
Common stock issued for settlement of accounts payable -related party	759,071	497,500
Common stock issued for accounts payable - related party and prepaid rent	33,749	0
Common stock issued for principal and interest accrual on Convertible Debentures	55,692	0
Common stock issued for Senior Secured Convertible Debentures	29,800	0
Common stock issued for payment on note payable-related party	372,160	0
Cashless exercise of warrants	497	70
Warrants issued to pay shareholder loan	0	125,022
Warrants issued for settlement of rent liability and prepaid rent	$0	$116,250

NATURE_OF_BUSINESS_AND_BASIS_O

NATURE OF BUSINESS AND BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2014
NATURE OF BUSINESS AND BASIS OF PRESENTATION [Text Block]	'
	NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION
	Hybrid Coating Technologies Inc. (the “Company”, “HCT”) formerly EPOD Solar Inc., was incorporated in the State of Nevada on July 8, 2010.
	The Company manufactures and sells under license, alternative non-toxic (isocyanate-free) polyurethane, Green Polyurethane™, including coatings and raw binder ingredients (Green Polyurethane Monolithic Floor Coating and Green Polyurethane™ Binder).
	The accompanying consolidated financial statements, which should be read in conjunction with the financial statements and footnotes of Hybrid Coating Technologies Inc., included in Form 10-K filed on May 2, 2014 with the Securities and Exchange Commission, are unaudited, but have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the period ended September 30, 2014 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2014.
	Going Concern
	The Company also remains highly dependent upon funding from non-operational sources. The Company’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred net losses of approximately $20,711,000 since inception, and has a working capital deficit of approximately $4,023,000 as of September 30, 2014. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties.
	There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support The Company’s working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available the Company may be required to curtail or cease its operations.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block]	'
	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation - The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s fiscal year end is December 31.
	Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Nanotech Industries International Inc. All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.
	Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.
	Intangible Assets - Intangible assets are comprised of intellectual property which is amortized on a straight-line basis over the assets’ respective life, 24 months, 36 months, 60 months and 120 months. Intellectual property with a perpetual life in not amortized.
	Impairment of Long-Lived Assets – Long-lived assets to be held and used are reviewed for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of such asset may not be recoverable. The determination of recoverability of long-lived assets is based on an estimate of undiscounted future cash flows resulting from the use of the asset or its disposition. Measurement of an impairment loss for long-lived assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or net realizable value.
	Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, goods are delivered, sales price is determinable, and collection is reasonably assured.
	Fair Value – ASC 820 defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
	Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.
	Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.
	As of September 30, 2014 and 2013, the significant inputs to the Company’s derivative liability calculation were Level 3 inputs.
	Stock-Based Compensation – For stock and stock options awarded in return for services rendered, the expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight-line basis over the service period, which is the vesting period. The Company estimates forfeitures that it expects will occur and records expense based upon the number of awards expected to vest.
	Earnings (Loss) Per Share - Basic net loss per share amounts are computed by dividing the net loss by the weighted average number of common shares outstanding over the reporting period. In periods in which the Company reports a net loss, dilutive securities are excluded from the calculation of diluted net loss per share amounts as the effect would be anti-dilutive.
	For nine months ended September 30, 2014 and 2013, the following convertible debt and warrants to purchase shares of common stock were excluded from the computation of diluted net loss per share, as the inclusion of such shares would be anti-dilutive:
		Nine Months Ended
		September 30,
		2014	2013
	Convertible debt	5,534,074	3,108,482
	Stock warrants	8,581,592	4,589,428
		14,115,666	7,697,910
	Recently Issued Accounting Pronouncements – In June 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-10 “Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation”. ASU 2014-10 eliminates all incremental financial reporting requirements for development stage entities by removing ASC Topic 915 “Development Stage Entities”, from the FASB Accounting Standards Codification. The ASU 2014-10 clarified that the guidance in Topic 275 “Risks and Uncertainties” is applicable to entities that have not yet commenced operations. Accordingly, upon adopting the ASU 2014-10 and eliminating development stage information, entities should re-evaluate their disclosures under Topic 275. The Company decided to early adopt this pronouncement as of the second quarter of 2014.
	Subsequent Events – The Company has evaluated all transactions occurring between the period ended September 30, 2014, and through the date of issuance of the consolidated financial statements for disclosure consideration.

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2014
INTANGIBLE ASSETS [Text Block]	'
	NOTE 3 – INTANGIBLE ASSETS
	During 2010 and 2011 the Company acquired licensing rights from Nanotech Industries, Inc., (“NTI” or “Licensor”, a privately-held entity deemed a related party by virtue of common ownership and control), for the rights to manufacture and distribute environmentally safe coatings (“Coating Products”) using NTI’s technology. As part of the original licensing agreement (“Agreement”) signed on July 12, 2010 (see table below) the Company has the option to obtain rights for the rest of the world on an exclusive perpetual basis, in exchange for the issuance of stock to equal 62.5% of the Company’s total shares. If this option is exercised, NTI would obtain voting control of the Company.
	Following is a summary of the licenses acquired to date from NTI:
			Licensed Region			Carrying
		License Rights		Term (date) of	Original	Value at	Carrying
		Overview		License	Cost	September 30,
						2014	Value
							at December 31,
							2013
	A	Coating	North America	12-Jun-10	$500,000	$0	$0
		Products		6 years
	B	Coating	Russian Territory	17-Mar-11	$150,000	$30,800	$34,400
		Products		10 years
	C	Coating	European	7-Jul-11	$1,250,000	$304,970	$410,540
		Products	Continent	5 years
	D	Spray Foam	North America,		$500,000	$399,315	$0
		Insulation	European	6-May-14
			Continent and	2 years
			Russian Territory
		Total			$2,400,000	$735,085	$444,940
	On October 18, 2011, the Company and NTI entered into a second Licensing Agreement (“Second Agreement”) granting the Company option (“Sealant Option”) to be exercised within six months of the signing of the Licensing Agreement, for the manufacturing and sale of environmentally safe adhesives and sealants (“Sealant Products”) as follows:
		1	The Company shall issue to NTI a one-time licensing fee (“Sealant Shares”), an aggregate number of shares of the Company’s restricted common stock which shall give NTI, immediately upon such issuance of shares, an incremental 15% (fifteen percent) ownership stake in the Company.
		2	NTII shall pay to NTI a royalty of 7.5% (seven and one half percent) of gross revenue from the sale of the Sealant Products (“Royalty”) for the duration of this Agreement.
	On December 6, 2011, the Company notified NTI of its intent to exercise the Sealant Option. To date, the Company has not issued the Sealant Shares and the Sealant Option has expired. The Company intends to renegotiate the Sealant Option once the Company has determined it has commercial viability.
	On June 28, 2013, the Company and NTI entered into a third amendment to the Licensing Agreement whereby NTI granted the Company an extension of thirty-six months on the exclusivity period to July 12, 2016.
	On December 13, 2013, the Company entered into a fourth amendment to the Licensing Agreement, whereby the license to sell and manufacture the Licensor’s products has been expanded to include polyurethane foam for the textile industry.
	On March 31, 2014, the Company and NTI entered into a fifth amendment to the Licensing Agreement, whereby the license to sell and manufacture Licensor’s products has been expanded to include synthetic leather, sealants and adhesives (“Added Applications”). In consideration for the Added Applications, the Company shall pay the Licensor an amount equal to US $2,000,000 (two million USD) (“Consideration”), to be paid within 36 months of the execution of this Fifth Amendment Agreement (“Deadline”). Should the Company not pay the Consideration within the Deadline, the Company shall lose all rights to the Added Applications. To date the company has not paid any consideration pertaining to the Added Applications.
	On April 9, 2014, the Company signed a sixth amendment to the Licensing Agreement with NTI extending the terms of the note from 24 months to 42 months making it payable by May 29, 2015.
	On May 6, 2014, the Company signed a seventh amendment to the Licensing Agreement with NTI whereby the license to sell and manufacture Licensor’s products has been expanded to include spray foam insulation (“SFI Application ”).In consideration for the SFI Application:
		1)	The Company shall pay the Licensor an amount equal to US $500,000 (“Consideration”) by May 6, 2015. Should the Company not pay the Consideration within the Deadline, the Company shall lose all rights to the SFI Application.
		2)	The Company shall issue to NTI an aggregate number of shares of common stock which shall give NTI , immediately upon such issuance of shares an additional 15% ownership stake in the Company (“ 15% Share Issuance”, “Exclusivity Shares”), to be issued to the Licensor within 24 months of the execution of this Seventh Amendment Agreement (“Issuance Deadline”). Should the 15% Share Issuance not be issued within the Issuance Deadline, the Company shall lose the exclusivity to the manufacturing and sale for the SFI Application and shall solely retain such rights to the SFI Application on a non-exclusive basis.
	On August 19, 2014, the Company signed an eighth amendment to the Licensing Agreement with NTI whereby the parties amended the Agreement to expand the definition of the Exclusivity Shares for various territories and to include warrants equal to the number of shares to be issued in the 15% share issuance at the sole discretion of the Licensor, which warrants shall include a cashless exercise and be exercisable at a price per share equal to the common stock par value and expiring 10 years from the date of issuance.
	On September 10, 2014, the Company signed a ninth amendment to the Licensing Agreement with NTI whereby the parties amended the Agreement (and subsequent Amendments) to expand the definition of certain licensing fees and consideration, to include payment in shares of the Company’s common stock and/or warrants at the sole discretion of the Company, which shares shall have a fair market value calculated as the closing price reported by the over-the-counter market for the previous trading day (“Shares”) and, which warrants shall include a cashless exercise and be exercisable at a price per share equal to the Common Stock par value and expiring 10 years from the date of issuance. As of November 19, 2014, the Exclusivity Shares have not been issued.
	On July 23, 2014, the Company issued 8,113,116 shares valued at $892,443 based on the market price on the date of grant as payment for the Spray Foam Insulation License and the European License, the Company applied $500,000 against the amounts owing for the SFI Application purchase and $372,160 for the European License, and the remaining $20,283 as a loss on settlement of debt.
	Intangibles activity is as follows for the nine months ended September 30, 2014 and 2013:
			September 30,			September 30,
			2014			2013
	Intangible asset, net, beginning of period	$	444,940		$	626,963
	Acquisitions		500,000			-
	Less: current amortization		(209,855	)		(145,633	)
	Total intangible assets, net	$	735,085		$	481,330
	The balance of intangible assets, net is as follows:
			30-Sep-14			31-Dec-13
	Intangible assets	$	1,618,083		$	1,118,083
	Less, accumulated amortization		(882,998	)		(673,143	)
	Intangible assets, net	$	735,085		$	444,940

LOANS_PAYABLE

LOANS PAYABLE	9 Months Ended
	Sep. 30, 2014
LOANS PAYABLE [Text Block]	'
	NOTE 4 – LOANS PAYABLE
	Loans payable include a loan from a non-related party that was issued for $75,000 on November 16, 2010 and was repayable on May 16, 2011 with a 10% premium. This $7,500 premium has been amortized and on April 29, 2011, the lender converted $55,000 of this debt to convertible debentures. The balance at September 30, 2014 and December 31, 2013 was $27,500, and the loan is currently in default. The Company has not received any notices from the loan holder with respect to the defaults.
	In 2012, the Company entered into various loan agreements totaling $681,500 at interest rates ranging from 15%-25%. These loans are all currently in default. The creditors have not called these loans.
	In 2013, the Company entered into various loan agreements totaling $268,500, at interest rates ranging from 15%-16%. These loans are all currently in default. The creditors have not called these loans.
	The Company recorded $5,455 and $26,913 of interest expense related to the debt discount during the nine months ended September 30, 2014 and 2013, respectively. During the nine months ended September 30, 2014 and 2013, total interest expense was $128,802 and $110,802, respectively, and the total interest paid was $25,554 and $55,173, respectively. At September 30, 2014, the unamortized debt discount was $0 compared to $5,455 as of December 31, 2013.

LOANS_PAYABLE_SHAREHOLDERS

LOANS PAYABLE SHAREHOLDERS	9 Months Ended
	Sep. 30, 2014
LOANS PAYABLE SHAREHOLDERS [Text Block]	'
	NOTE 5 – LOANS PAYABLE – SHAREHOLDERS
	During the year ended December 31, 2013, the Company received $708,846 in shareholder advances and repaid $360,696. Except for demand loans totaling $653,040 and a shareholder loan totaling $72,457 originally maturing July 20, 2014 that was extended to January 20, 2015, the remaining loans totaling $973,020 are all due and in default. The creditors have not called these loans.
	During the nine months ended September 30, 2014, the Company received $896,651 in shareholder loans and repaid $426,190.
	During the nine months ended September 30, 2014 and 2013, the Company recorded interest expense related to the amortization of debt discounts of $21,981 and $48,802, respectively, related to all loans from shareholders. As of September 30, 2014 and 2013, the total interest expense was $78,434 and $61,818, respectively, and the total interest paid on loans from shareholders was $8,609 and $30,492. The Company had an outstanding balance of $1,842,990 and $1,343,562, with related discounts of $0 and $21,980 for the nine months ended September 30, 2014 and year ended December 31, 2013, respectively.

CONVERTIBLE_DEBENTURES

CONVERTIBLE DEBENTURES	9 Months Ended
	Sep. 30, 2014
CONVERTIBLE DEBENTURES [Text Block]	'
	NOTE 6 – CONVERTIBLE DEBENTURES
	On April 29, 2011, the Company issued convertible debentures for proceeds of $1,201,000 (the “April 29” debenture) and on February 21, 2012, issued an additional $119,500 (the “Feb 21” debenture and together the “Debentures”) with a maturity of 36 months and a coupon rate of 10% per annum payable in cash or capital stock at the Company’s discretion. The debentures are held by third parties and by non-controlling shareholders, and are convertible as follows:
	April 29, 2011 convertible debentures:
	-by dividing the conversion amount by a conversion factor of 1.4 yielding Units of the Company where each Unit (at a price of $1.40 per Unit), is comprised of 1 share of common stock and one half of a warrant to purchase a share of common stock of the Company with an exercise price of $2.00 per share and a maturity at April 29, 2014. Warrants are exercisable at the option of the holder at any time prior to maturity.
	February 21, 2012 convertible debentures:
	-by dividing the conversion amount by a conversion factor of 1.45 yielding Units of the Company where each Unit (at a price of $1.45 per Unit), is comprised of 1 share of common stock and one half of a warrant to purchase a share of common stock of the Company with an exercise price of $2.10 per share and a maturity at February 21, 2015. Warrants are exercisable at the option of the holder at any time prior to maturity.
	Both debentures carry an anti-dilution provision. The conversion price applicable to the debentures is subject to reset in the event of a Dilutive Issuance (as defined in the debenture agreement) by the Company. A Dilutive Issuance excludes shares or options issued to employees, officers, directors or consultants pursuant to stock option plans approved by the Board of Directors.
	The Company recorded a corresponding discount of $46,721 and $558,248 against the carrying value of the convertible debentures during the years ended December 31, 2012 and 2011, respectively. The discounts are amortized using the effective interest method over the term of the debt.
	On November 20, 2013, the Company entered into an amendment agreement modifying its terms with both the April 29 and Feb 21 debenture holders as follows:
	1) The maturity date of the Debentures, was extended by a period of 24 months, to April 29, 2016 and February 21, 2017, respectively,
	2) Each Unit into which the Debentures are convertible shall be comprised of 2 stock purchase warrants at an exercise price per share equal to the conversion price. The warrants shall expire 36 months from the date of issuance.
	As consideration for the amendments, the Company issued a total of 400,152 shares to the debenture holders at a price of $0.33 per share.
	The amendment resulted in an extinguishment of both the April 29 and February 21 Debentures as the present value of the new convertible debentures exceeded the present value of the old debentures by greater than 10%.
	The Company measured the fair value of the embedded derivatives in the April 29 Debentures, which was $76,322 on the date of the amendments and recorded a gain of $61,238 for the change in fair value of the derivative liabilities.
	The Company recorded a loss on extinguishment of debt on the April 29 debenture of $530,541 and the new debt was recorded at its fair value of $1,268,453 with a corresponding derivative liability of $357,790.
	The Company measured the fair value of the embedded derivatives in the February 21 debentures, which was $23,090 on the date of the amendments and recorded a gain of $6,071 for the change in fair value of the derivative liabilities.
	The Company recorded a loss on extinguishment of debt on the February 21 debenture of $113,195 and the new debt was recorded at its fair value of $128,405 with a corresponding derivative liability of $102,150.
	Interest of $98,766 has been accrued for the nine months ended September 30, 2014 and September 30, 2013. Interest of $55,692 and principal of $ $76,358 was paid through the issuance of 432,454 shares at a fair value of $132,050 during the nine months ended September 30, 2014. During the nine months ended September 30, 2013, $140,877 interest was paid through the issuance of 420,567 shares of common stock. The balance of the debentures both at September 30, 2014 and December 31, 2013 was $1,320,500 and $1,396,858, respectively.

CONVERTIBLE_NOTE

CONVERTIBLE NOTE	9 Months Ended
	Sep. 30, 2014
CONVERTIBLE NOTE [Text Block]	'
	NOTE 7 – CONVERTIBLE NOTE
	On July 23, 2014, the Company entered into an agreement with an investor whereby the investor could lend a principal sum up to $250,000 including an original issue discount (“OID”) of $25,000. Upon signing, the investor was required to pay $100,000 with the OID prorated based on the actual consideration paid. The investor may pay additional amounts at its own discretion. The OID on the $100,000 investment was $11,111 and was recorded as debt discount. If the Company pays the investor within 90 days then there is 0% interest, and if the Company pays after 90 days then there is a one-time interest charge of 12% applied to the outstanding balance. The maturity date is 2 years from the date of each borrowing and the outstanding balance and any interest is due and payable. The note is convertible into common shares of the Company. The conversion price is 60% of the lowest trade price of the 25 trading days prior to the conversion.
	In the event that conversion shares are not deliverable, an additional 10% discount will apply; and if the shares are ineligible for deposit into the Depository Trust Company system and only eligible for Xclearing deposit an additional 5% discount shall apply; and in the case of both events an additional cumulative 15% discount shall apply.
	The Company determined that the conversion option was a derivative, accordingly, the Company recorded a derivative liability of $153,702, a debt discount of $100,000 and recognized the difference as additional interest.

SENIOR_SECURED_CONVERTIBLE_DEB

SENIOR SECURED CONVERTIBLE DEBENTURES	9 Months Ended
	Sep. 30, 2014
SENIOR SECURED CONVERTIBLE DEBENTURES [Text Block]	'
	NOTE 8 – SENIOR SECURED CONVERTIBLE DEBENTURES
	On August 16, 2010, the Company entered into a securities purchase agreement with a third party for the subscription of senior secured convertible debentures (“SSCD”) for an amount of $400,000. The debentures have a maturity date of August 16, 2012 with a coupon of 10% and convert at the option of the holder into shares of common stock of the Company at a price of $0.75 per share. The notes are secured by all assets of the Company. The subscriber also received 533,336 Series A warrants with a maturity of 1 year and an exercise price of $1.25 and 133,360 Series B warrants with a term of 3 years and an exercise price of $1.50. The debentures and Series A warrants carry registration rights whereby upon the consummation of the reverse merger with Nanotech, the shares underlying the debentures and Series A warrants will be registered as soon as is practicable. All prices and warrants issued have been adjusted for the post-acquisition of Nanotech by HCT.
	The Company is in default of payment of the debentures which matured on August 16, 2012. No notices have been issued by the debenture holder.
	The obligations of the Company under the SSCD will rank senior to all outstanding and future indebtedness of the Company and shall be secured by a first priority, perfected security interest in all the assets of the Company.
	During the period ended September 30, 2014, the Company issued 100,000 shares to pay accrued interest of $29,800.

DERIVATIVE_LIABILITIES

DERIVATIVE LIABILITIES	9 Months Ended
	Sep. 30, 2014
DERIVATIVE LIABILITIES [Text Block]	'
	NOTE 9 – DERIVATIVE LIABILITIES
	The embedded conversion features in the convertible debentures and attached warrants are accounted for as a derivative liability. The warrants contain full ratchet reset features (subject to adjustment for dilutive share issuances) and should be valued as a derivative liability.
	The valuation of the derivative liability attached to the Debentures arrived at through the use of multinomial lattice models based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the note that were analyzed and incorporated into the model included the conversion feature with the reset provisions and the call/redemption options. Based on these features, there are six primary events that can occur: payments are made in cash; payments are made with stock; the holder converts upon receiving a change notice; the holder converts the note; the Issuer redeems the note; or the company defaults on the note.
	The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. interest rates, stock price, conversion price, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. Probabilities were assigned to each of these scenarios over the remaining term of the note based on management projections. This led to a cash flow projection over the life of the note and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liability of $558,248 as of April 29, 2011 and of $46,721 at February 21, 2012, which was recorded to additional paid-in capital for each issuance. The Company recorded an unrealized gain (loss) of ($264,366) and $360,461 to reflect the value of the derivative liability as $816,488 and $166,721 as of December 31, 2013 and 2012, respectively. To reflect the change in fair value for the nine months ended September 30, 2014, the Company recorded a gain of $777,685.
	For the convertible note referred to in in Note 7, the Company recorded an initial derivative liability of $153,702 with a corresponding charge to discount on note of $100,000 and interest expense of $53,702. The Company is amortizing the discount over the note’s term of 2 years. The Company arrived at the fair value of the derivative liability based on Black-Scholes and the following assumptions:
	Expected volatility		231%
	Exercise price	$	0.05
	Stock price	$	0.09
	Expected life		2 years
	Risk-free interest rate		0.50%
	Dividend yield	$	Nil
	The following is a summary of the assumptions used in the multinomial lattice valuation model as of the nine months ended September 30, 2014 and 2013, respectively:
			30-Sep-14			30-Sep-13
	Expected volatility		105%			77% - 277%
	Exercise price	$	0.3954 - $0.4095		$	0.0391 - $0.400
	Stock price	$	0.09		$	0.33
	Expected life		1.60 – 2.43 years			0.58 – 1.39 years
	Dividend yield	$	Nil		$	Nil
	The following table sets forth a reconciliation of changes in the fair value of financial assets and liabilities classified as Level 3 in the fair value hierarchy:
			Significant Unobservable Inputs
			(Level 3)
			Nine Months Ended
			September 30,
			2014			2013
	Beginning balance	$	816,488		$	166,721
	Total gains		(777,685	)		(47,442	)
	Settlements		-			-
	Additions		153,702			-
	Transfers		-			-
	Ending balance	$	192,505		$	119,279
	Change in unrealized gains (losses) included in earnings relating to derivatives still held as of September 30, 2014 and 2013	$	777,685			(47,442	)

STOCKHOLDERS_DEFICIT

STOCKHOLDERS DEFICIT	9 Months Ended
	Sep. 30, 2014
STOCKHOLDERS DEFICIT [Text Block]	'NOTE 10 – STOCKHOLDERS’ DEFICIT
	During the nine months ended September 30, 2014, the Company issued the following shares:
	- 14,245,000 shares of common stock to a shareholder-creditor and a related party for payment valued at $2,705,150 based on the market price on the date of grant, against accounts payable and accrued liabilities to related parties of $805,000 and recognized a loss on settlement in the amount of $1,900,150.
	- 8,113,116 shares of common stock to the Licensor for payment valued at $892,443, based on the market price on the date of grant, against a note-payable to related party of $872,160 and recognized a loss on settlement in the amount of $20,283.
	- 432,454 shares at a fair value of $132,050 paying accrued interest of $55,692 and principal of $76,358.
	- 418,604 shares of common stock to a related party landlord as payment, valued at $46,046 based on the market price on the date of grant, against accounts payable and accrued liabilities to a related party of $33,750, prepaid rent of $11,250 and recognized a loss on settlement in the amount of $1,046.
	- 154,315 shares of common stock to an officer as payment, valued at $92,590 based on the market price on the date of grant, against payroll liabilities (included in accounts payable and accrued liabilities) of $50,924 and recognized a loss on settlement in the amount of $41,666.
	- 3,504,340 shares to consultants as payment for services with a fair value of $493,757 based on the market price on the date of grant.
	- 100,000 shares to the Senior Secured Convertible Debenture holder for fair value of $29,800 as payment for accrued interest.
	- 50,000 shares to a creditor at fair value of $14,900 as payment for accrued interest on loans payable.
	- 290,310 shares of common stock to a shareholder-creditor valued at $40,838 ; $23,135 for interest expense, $10,500 discount ($10,500 amortized as interest expense at September 30, 2014), $2,940 for accrued interest of and $4,263 for a recognized loss on settlement based on the market price on the date of grant.
	Warrants
	During the nine months ended September 30, 2014, the Company issued 1,114,664 warrants to shareholders and consultants for consulting services at a fair value of $150,973 (recorded as stock-based compensation with a corresponding increase in additional paid-in capital, using the Black-Scholes method according to the following assumptions:
	Expected volatility		269% - 283%
	Exercise price	$	0.001
	Stock price	$	0.08 - $0.70
	Expected life		5 years
	Risk-free interest rate		1.65% - 1.80%
	Dividend yield	$	Nil
	In addition, during the nine months ended September 30, 2014, warrant holders exercised 500,000 warrants for 496,166 shares on a cashless basis with a reduction in additional paid in capital of $496. Also, 300,000 shares were issued on the exercise of 300,000 warrants for cash proceeds of $300.
	A summary of the activity in the Company's warrants during the three months ended September 30, 2014 is presented below:
						Weighted
			Number of			Average
			Warrants			Exercise
						Price
	Outstanding and exercisable, at December 31, 2013		8,266,928		$	0.12
	New issuances		1,114,664		$	0.001
	Exercised		(800,000	)	$	0.001
	Outstanding and exercisable, at September 30, 2014		8,581,592		$	0.11
	In addition to these regular warrants, there are 533,336 Series A warrants with an exercise price of $0.39 per share and a maturity date of February 28, 2018.
	During the nine months ended September 30, 2014, the Company recorded $491,656 for amortization expense.
	The intrinsic value of warrants outstanding at September 30, 2014 was $527,782.
	Contingent Warrant Issuance
	On July 20, 2012, the Company’s board of directors approved the issuance of 300,000 stock purchase warrants, exercise price of $0.001 per share and five-year life, from date of issuance, to the Company’s President, Joseph Kristul, contingent upon his successful negotiation of a major sales contract. The major sales contract agreement has not yet been reached by the Company and no warrants have been issued.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2014
RELATED PARTY TRANSACTIONS [Text Block]	'
	NOTE 11– RELATED PARTY TRANSACTIONS
	Fees Charged by Shareholder
	During the nine months ended September 30, 2014 and 2013, the Company was charged $522,000 and $398,000 by an outside consultant, who is also a shareholder, for professional fees, expenses and commissions. The Company has an outstanding balance in accounts payable and accrued liabilities to related parties as of September 30, 2014 and December 31, 2013 of $247,852 and $427,842, respectively.
	Principal Debt Payments
	During the nine months ended September 30, 2014, the Company made cash principal payments of $274,000 on its note payable to NTI related to the 2011 acquisition of the license rights for coatings in Europe. The note matures on May 29, 2015, does not bear interest, and no payments are required prior to maturity. The Company also issued a new note expiring May 6, 2016 for $500,000. During the quarter, the Company issued 8,113,116 common shares as payment against these notes, $500,000 applied against the new note expiring May 6, 2016 and $372,160 against the note maturing on May 29, 2015. The balance of this note was $36,291 and $682,451 at September 30, 2014 and December 31, 2013, respectively.
	Shared Administrative Costs
	The Company shares office space and certain personnel with NTI. Costs are allocated among the parties based on usage. Rent expense for the nine months ended June 30, 2014 and 2013 was $33,750.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2014
SUBSEQUENT EVENTS [Text Block]	'
	NOTE 12 – SUBSEQUENT EVENTS
	Subsequent to the nine months ended September 30, 2014 the Company has issued the following shares:
	- 3,450,000 shares of common stock to a shareholder/creditor valued on the dates of issuances for $349,500. $182,500, as payment for accounts payable and accrued liabilities to a related party and the remaining $167,000 was recorded as loss on settlement of debt.
	- 380,000 shares on cash-less exercise of 380,000 warrants. All shares issued were valued using the market price on the date of grant.

Recovered_Sheet1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Basis of Presentation [Policy Text Block]	'
	Basis of Presentation - The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America and are presented in US dollars. The Company’s fiscal year end is December 31.
Principles of Consolidation [Policy Text Block]	'
	Principles of Consolidation - The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Nanotech Industries International Inc. All significant inter-company balances and transactions have been eliminated in the consolidated financial statements.
Use of Estimates [Policy Text Block]	'
	Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.
Intangible Assets [Policy Text Block]	'
	Intangible Assets - Intangible assets are comprised of intellectual property which is amortized on a straight-line basis over the assets’ respective life, 24 months, 36 months, 60 months and 120 months. Intellectual property with a perpetual life in not amortized.
Impairment of Long-Lived Assets [Policy Text Block]	'
	Impairment of Long-Lived Assets – Long-lived assets to be held and used are reviewed for impairment on an annual basis or whenever events or changes in circumstances indicate that the carrying amount of such asset may not be recoverable. The determination of recoverability of long-lived assets is based on an estimate of undiscounted future cash flows resulting from the use of the asset or its disposition. Measurement of an impairment loss for long-lived assets that management expects to hold and use is based on the fair value of the asset. Long-lived assets to be disposed of are reported at the lower of carrying amount or net realizable value.
Revenue Recognition [Policy Text Block]	'
	Revenue Recognition – Revenue is recognized when persuasive evidence of an arrangement exists, goods are delivered, sales price is determinable, and collection is reasonably assured.
Fair Value [Policy Text Block]	'
	Fair Value – ASC 820 defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
	Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
	Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.
	Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.
	As of September 30, 2014 and 2013, the significant inputs to the Company’s derivative liability calculation were Level 3 inputs.
Stock-Based Compensation [Policy Text Block]	'
	Stock-Based Compensation – For stock and stock options awarded in return for services rendered, the expense is measured at the grant-date fair value of the award and recognized as compensation expense on a straight-line basis over the service period, which is the vesting period. The Company estimates forfeitures that it expects will occur and records expense based upon the number of awards expected to vest.
Earnings (Loss) per Share [Policy Text Block]	'
	Earnings (Loss) Per Share - Basic net loss per share amounts are computed by dividing the net loss by the weighted average number of common shares outstanding over the reporting period. In periods in which the Company reports a net loss, dilutive securities are excluded from the calculation of diluted net loss per share amounts as the effect would be anti-dilutive.
	For nine months ended September 30, 2014 and 2013, the following convertible debt and warrants to purchase shares of common stock were excluded from the computation of diluted net loss per share, as the inclusion of such shares would be anti-dilutive:
		Nine Months Ended
		September 30,
		2014	2013
	Convertible debt	5,534,074	3,108,482
	Stock warrants	8,581,592	4,589,428
		14,115,666	7,697,910
Recently Issued Accounting Pronouncements [Policy Text Block]	'
	Recently Issued Accounting Pronouncements – In June 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-10 “Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation”. ASU 2014-10 eliminates all incremental financial reporting requirements for development stage entities by removing ASC Topic 915 “Development Stage Entities”, from the FASB Accounting Standards Codification. The ASU 2014-10 clarified that the guidance in Topic 275 “Risks and Uncertainties” is applicable to entities that have not yet commenced operations. Accordingly, upon adopting the ASU 2014-10 and eliminating development stage information, entities should re-evaluate their disclosures under Topic 275. The Company decided to early adopt this pronouncement as of the second quarter of 2014.
Subsequent Events [Policy Text Block]	'
	Subsequent Events – The Company has evaluated all transactions occurring between the period ended September 30, 2014, and through the date of issuance of the consolidated financial statements for disclosure consideration.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2014
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
		Nine Months Ended
		September 30,
		2014	2013
	Convertible debt	5,534,074	3,108,482
	Stock warrants	8,581,592	4,589,428
		14,115,666	7,697,910

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2014
Schedule of License Acquired From NTI [Table Text Block]	'
			Licensed Region			Carrying
		License Rights		Term (date) of	Original	Value at	Carrying
		Overview		License	Cost	September 30,
						2014	Value
							at December 31,
							2013
	A	Coating	North America	12-Jun-10	$500,000	$0	$0
		Products		6 years
	B	Coating	Russian Territory	17-Mar-11	$150,000	$30,800	$34,400
		Products		10 years
	C	Coating	European	7-Jul-11	$1,250,000	$304,970	$410,540
		Products	Continent	5 years
	D	Spray Foam	North America,		$500,000	$399,315	$0
		Insulation	European	6-May-14
			Continent and	2 years
			Russian Territory
		Total			$2,400,000	$735,085	$444,940
Schedule of lntangibles Activity [Table Text Block]	'
			September 30,			September 30,
			2014			2013
	Intangible asset, net, beginning of period	$	444,940		$	626,963
	Acquisitions		500,000			-
	Less: current amortization		(209,855	)		(145,633	)
	Total intangible assets, net	$	735,085		$	481,330
Schedule of Intangible Assets [Table Text Block]	'
			30-Sep-14			31-Dec-13
	Intangible assets	$	1,618,083		$	1,118,083
	Less, accumulated amortization		(882,998	)		(673,143	)
	Intangible assets, net	$	735,085		$	444,940

DERIVATIVE_LIABILITIES_Tables

DERIVATIVE LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2014
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	'
	Expected volatility		231%
	Exercise price	$	0.05
	Stock price	$	0.09
	Expected life		2 years
	Risk-free interest rate		0.50%
	Dividend yield	$	Nil
Schedule of Valuation Assumptions of Derivative Liabilities [Table Text Block]	'
			30-Sep-14			30-Sep-13
	Expected volatility		105%			77% - 277%
	Exercise price	$	0.3954 - $0.4095		$	0.0391 - $0.400
	Stock price	$	0.09		$	0.33
	Expected life		1.60 – 2.43 years			0.58 – 1.39 years
	Dividend yield	$	Nil		$	Nil
Schedule of fair value assets and liabilities measured on recurring basis table text block [Table Text Block]	'
			Significant Unobservable Inputs
			(Level 3)
			Nine Months Ended
			September 30,
			2014			2013
	Beginning balance	$	816,488		$	166,721
	Total gains		(777,685	)		(47,442	)
	Settlements		-			-
	Additions		153,702			-
	Transfers		-			-
	Ending balance	$	192,505		$	119,279
	Change in unrealized gains (losses) included in earnings relating to derivatives still held as of September 30, 2014 and 2013	$	777,685			(47,442	)

STOCKHOLDERS_DEFICIT_Tables

STOCKHOLDERS DEFICIT (Tables)	9 Months Ended
	Sep. 30, 2014
Schedule of Warrants Valuation Assumptions [Table Text Block]	'
	Expected volatility		269% - 283%
	Exercise price	$	0.001
	Stock price	$	0.08 - $0.70
	Expected life		5 years
	Risk-free interest rate		1.65% - 1.80%
	Dividend yield	$	Nil
Schedule of Warrants Activity [Table Text Block]	'
						Weighted
			Number of			Average
			Warrants			Exercise
						Price
	Outstanding and exercisable, at December 31, 2013		8,266,928		$	0.12
	New issuances		1,114,664		$	0.001
	Exercised		(800,000	)	$	0.001
	Outstanding and exercisable, at September 30, 2014		8,581,592		$	0.11

NATURE_OF_BUSINESS_AND_BASIS_O1

NATURE OF BUSINESS AND BASIS OF PRESENTATION (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Nature Of Business And Basis Of Presentation 1	$20,711,000
Nature Of Business And Basis Of Presentation 2	$4,023,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)	9 Months Ended
	Sep. 30, 2014
	M
Summary Of Significant Accounting Policies 1	24
Summary Of Significant Accounting Policies 2	36
Summary Of Significant Accounting Policies 3	60
Summary Of Significant Accounting Policies 4	120

INTANGIBLE_ASSETS_Narrative_De

INTANGIBLE ASSETS (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
	M
Intangible Assets 1	62.50%
Intangible Assets 2	15.00%
Intangible Assets 3	7.50%
Intangible Assets 4	$2,000,000
Intangible Assets 5	36
Intangible Assets 6	24
Intangible Assets 7	42
Intangible Assets 8	500,000
Intangible Assets 9	15.00%
Intangible Assets 10	15.00%
Intangible Assets 11	24
Intangible Assets 12	15.00%
Intangible Assets 13	15.00%
Intangible Assets 14	10
Intangible Assets 15	10
Intangible Assets 16	8,113,116
Intangible Assets 17	892,443
Intangible Assets 18	500,000
Intangible Assets 19	372,160
Intangible Assets 20	$20,283

LOANS_PAYABLE_Narrative_Detail

LOANS PAYABLE (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Loans Payable 1	$75,000
Loans Payable 2	10.00%
Loans Payable 3	7,500
Loans Payable 4	55,000
Loans Payable 5	27,500
Loans Payable 6	681,500
Loans Payable 7	15.00%
Loans Payable 8	268,500
Loans Payable 9	15.00%
Loans Payable 10	5,455
Loans Payable 11	26,913
Loans Payable 12	128,802
Loans Payable 13	110,802
Loans Payable 14	25,554
Loans Payable 15	55,173
Loans Payable 16	0
Loans Payable 17	$5,455

LOANS_PAYABLE_SHAREHOLDERS_Nar

LOANS PAYABLE SHAREHOLDERS (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Loans Payable Shareholders 1	$708,846
Loans Payable Shareholders 2	360,696
Loans Payable Shareholders 3	653,040
Loans Payable Shareholders 4	72,457
Loans Payable Shareholders 5	973,020
Loans Payable Shareholders 6	896,651
Loans Payable Shareholders 7	426,190
Loans Payable Shareholders 8	21,981
Loans Payable Shareholders 9	48,802
Loans Payable Shareholders 10	78,434
Loans Payable Shareholders 11	61,818
Loans Payable Shareholders 12	8,609
Loans Payable Shareholders 13	30,492
Loans Payable Shareholders 14	1,842,990
Loans Payable Shareholders 15	1,343,562
Loans Payable Shareholders 16	0
Loans Payable Shareholders 17	$21,980

CONVERTIBLE_DEBENTURES_Narrati

CONVERTIBLE DEBENTURES (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	M
Convertible Debentures 1	$1,201,000
Convertible Debentures 2	119,500
Convertible Debentures 3	36
Convertible Debentures 4	10.00%
Convertible Debentures 5	1.4
Convertible Debentures 6	1.4
Convertible Debentures 7	1
Convertible Debentures 8	$2
Convertible Debentures 9	1.45
Convertible Debentures 10	1.45
Convertible Debentures 11	1
Convertible Debentures 12	$2.10
Convertible Debentures 13	46,721
Convertible Debentures 14	558,248
Convertible Debentures 15	24
Convertible Debentures 16	2
Convertible Debentures 17	36
Convertible Debentures 18	400,152
Convertible Debentures 19	$0.33
Convertible Debentures 20	10.00%
Convertible Debentures 21	76,322
Convertible Debentures 22	61,238
Convertible Debentures 23	530,541
Convertible Debentures 24	1,268,453
Convertible Debentures 25	357,790
Convertible Debentures 26	23,090
Convertible Debentures 27	6,071
Convertible Debentures 28	113,195
Convertible Debentures 29	128,405
Convertible Debentures 30	102,150
Convertible Debentures 31	98,766
Convertible Debentures 32	55,692
Convertible Debentures 33	76,358
Convertible Debentures 34	432,454
Convertible Debentures 35	132,050
Convertible Debentures 36	140,877
Convertible Debentures 37	420,567
Convertible Debentures 38	1,320,500
Convertible Debentures 39	$1,396,858

CONVERTIBLE_NOTE_Narrative_Det

CONVERTIBLE NOTE (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
	D
Convertible Note 1	$250,000
Convertible Note 2	25,000
Convertible Note 3	100,000
Convertible Note 4	100,000
Convertible Note 5	11,111
Convertible Note 6	90
Convertible Note 7	0.00%
Convertible Note 8	90
Convertible Note 9	12.00%
Convertible Note 10	2
Convertible Note 11	60.00%
Convertible Note 12	25
Convertible Note 13	10.00%
Convertible Note 14	5.00%
Convertible Note 15	15.00%
Convertible Note 16	153,702
Convertible Note 17	$100,000

SENIOR_SECURED_CONVERTIBLE_DEB1

SENIOR SECURED CONVERTIBLE DEBENTURES (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
Senior Secured Convertible Debentures 1	$400,000
Senior Secured Convertible Debentures 2	10.00%
Senior Secured Convertible Debentures 3	$0.75
Senior Secured Convertible Debentures 4	533,336
Senior Secured Convertible Debentures 5	1
Senior Secured Convertible Debentures 6	1.25
Senior Secured Convertible Debentures 7	133,360
Senior Secured Convertible Debentures 8	3
Senior Secured Convertible Debentures 9	1.5
Senior Secured Convertible Debentures 10	100,000
Senior Secured Convertible Debentures 11	$29,800

DERIVATIVE_LIABILITIES_Narrati

DERIVATIVE LIABILITIES (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
Derivative Liabilities 1	$558,248
Derivative Liabilities 2	46,721
Derivative Liabilities 3	264,366
Derivative Liabilities 4	360,461
Derivative Liabilities 5	816,488
Derivative Liabilities 6	166,721
Derivative Liabilities 7	777,685
Derivative Liabilities 8	153,702
Derivative Liabilities 9	100,000
Derivative Liabilities 10	$53,702
Derivative Liabilities 11	2

STOCKHOLDERS_DEFICIT_Narrative

STOCKHOLDERS DEFICIT (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Stockholders Deficit 1	14,245,000
Stockholders Deficit 2	$2,705,150
Stockholders Deficit 3	805,000
Stockholders Deficit 4	1,900,150
Stockholders Deficit 5	8,113,116
Stockholders Deficit 6	892,443
Stockholders Deficit 7	872,160
Stockholders Deficit 8	20,283
Stockholders Deficit 9	432,454
Stockholders Deficit 10	132,050
Stockholders Deficit 11	55,692
Stockholders Deficit 12	76,358
Stockholders Deficit 13	418,604
Stockholders Deficit 14	46,046
Stockholders Deficit 15	33,750
Stockholders Deficit 16	11,250
Stockholders Deficit 17	1,046
Stockholders Deficit 18	154,315
Stockholders Deficit 19	92,590
Stockholders Deficit 20	50,924
Stockholders Deficit 21	41,666
Stockholders Deficit 22	3,504,340
Stockholders Deficit 23	493,757
Stockholders Deficit 24	100,000
Stockholders Deficit 25	29,800
Stockholders Deficit 26	50,000
Stockholders Deficit 27	14,900
Stockholders Deficit 28	290,310
Stockholders Deficit 29	40,838
Stockholders Deficit 30	23,135
Stockholders Deficit 31	10,500
Stockholders Deficit 32	10,500
Stockholders Deficit 33	2,940
Stockholders Deficit 34	4,263
Stockholders Deficit 35	1,114,664
Stockholders Deficit 36	150,973
Stockholders Deficit 37	500,000
Stockholders Deficit 38	496,166
Stockholders Deficit 39	496
Stockholders Deficit 40	300,000
Stockholders Deficit 41	300,000
Stockholders Deficit 42	300
Stockholders Deficit 43	533,336
Stockholders Deficit 44	$0.39
Stockholders Deficit 45	491,656
Stockholders Deficit 46	$527,782
Stockholders Deficit 47	300,000
Stockholders Deficit 48	$0.00

RELATED_PARTY_TRANSACTIONS_Nar

RELATED PARTY TRANSACTIONS (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Related Party Transactions 1	$522,000
Related Party Transactions 2	398,000
Related Party Transactions 3	247,852
Related Party Transactions 4	427,842
Related Party Transactions 5	274,000
Related Party Transactions 6	500,000
Related Party Transactions 7	8,113,116
Related Party Transactions 8	500,000
Related Party Transactions 9	372,160
Related Party Transactions 10	36,291
Related Party Transactions 11	682,451
Related Party Transactions 12	$33,750

SUBSEQUENT_EVENTS_Narrative_De

SUBSEQUENT EVENTS (Narrative) (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Subsequent Events 1	3,450,000
Subsequent Events 2	$349,500
Subsequent Events 3	182,500
Subsequent Events 4	$167,000
Subsequent Events 5	380,000
Subsequent Events 6	380,000

Schedule_of_Antidilutive_Secur

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 1	$5,534,074
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 2	3,108,482
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 3	8,581,592
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 4	4,589,428
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 5	14,115,666
Summary Of Significant Accounting Policies Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share 6	$7,697,910

Schedule_of_License_Acquired_F

Schedule of License Acquired From NTI (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
Intangible Assets Schedule Of License Acquired From Nti 1	6
Intangible Assets Schedule Of License Acquired From Nti 2	$500,000
Intangible Assets Schedule Of License Acquired From Nti 3	0
Intangible Assets Schedule Of License Acquired From Nti 4	0
Intangible Assets Schedule Of License Acquired From Nti 5	10
Intangible Assets Schedule Of License Acquired From Nti 6	150,000
Intangible Assets Schedule Of License Acquired From Nti 7	30,800
Intangible Assets Schedule Of License Acquired From Nti 8	34,400
Intangible Assets Schedule Of License Acquired From Nti 9	5
Intangible Assets Schedule Of License Acquired From Nti 10	1,250,000
Intangible Assets Schedule Of License Acquired From Nti 11	304,970
Intangible Assets Schedule Of License Acquired From Nti 12	410,540
Intangible Assets Schedule Of License Acquired From Nti 13	2
Intangible Assets Schedule Of License Acquired From Nti 14	500,000
Intangible Assets Schedule Of License Acquired From Nti 15	399,315
Intangible Assets Schedule Of License Acquired From Nti 16	0
Intangible Assets Schedule Of License Acquired From Nti 17	2,400,000
Intangible Assets Schedule Of License Acquired From Nti 18	735,085
Intangible Assets Schedule Of License Acquired From Nti 19	$444,940

Schedule_of_lntangibles_Activi

Schedule of lntangibles Activity (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Intangible Assets Schedule Of Lntangibles Activity 1	$444,940
Intangible Assets Schedule Of Lntangibles Activity 2	626,963
Intangible Assets Schedule Of Lntangibles Activity 3	500,000
Intangible Assets Schedule Of Lntangibles Activity 4	0
Intangible Assets Schedule Of Lntangibles Activity 5	-209,855
Intangible Assets Schedule Of Lntangibles Activity 6	-145,633
Intangible Assets Schedule Of Lntangibles Activity 7	735,085
Intangible Assets Schedule Of Lntangibles Activity 8	$481,330

Schedule_of_Intangible_Assets_

Schedule of Intangible Assets (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Intangible Assets Schedule Of Intangible Assets 1	$1,618,083
Intangible Assets Schedule Of Intangible Assets 2	1,118,083
Intangible Assets Schedule Of Intangible Assets 3	-882,998
Intangible Assets Schedule Of Intangible Assets 4	-673,143
Intangible Assets Schedule Of Intangible Assets 5	735,085
Intangible Assets Schedule Of Intangible Assets 6	$444,940

Schedule_of_Derivative_Liabili

Schedule of Derivative Liabilities at Fair Value (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
Derivative Liabilities Schedule Of Derivative Liabilities At Fair Value 1	231.00%
Derivative Liabilities Schedule Of Derivative Liabilities At Fair Value 2	0.05
Derivative Liabilities Schedule Of Derivative Liabilities At Fair Value 3	0.09
Derivative Liabilities Schedule Of Derivative Liabilities At Fair Value 4	2
Derivative Liabilities Schedule Of Derivative Liabilities At Fair Value 5	0.50%
Derivative Liabilities Schedule Of Derivative Liabilities At Fair Value 6	$0

Schedule_of_Valuation_Assumpti

Schedule of Valuation Assumptions of Derivative Liabilities (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 1	105.00%
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 2	77.00%
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 3	277.00%
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 4	0.3954
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 5	$0.41
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 6	0.0391
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 7	0.4
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 8	0.09
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 9	0.33
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 10	1.6
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 11	2.43
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 12	0.58
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 13	1.39
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 14	0
Derivative Liabilities Schedule Of Valuation Assumptions Of Derivative Liabilities 15	$0

Schedule_of_fair_value_assets_

Schedule of fair value assets and liabilities measured on recurring basis table text block (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 1	$816,488
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 2	166,721
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 3	-777,685
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 4	-47,442
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 5	0
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 6	0
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 7	153,702
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 8	0
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 9	0
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 10	0
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 11	192,505
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 12	119,279
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 13	777,685
Derivative Liabilities Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table Text Block 14	($47,442)

Schedule_of_Warrants_Valuation

Schedule of Warrants Valuation Assumptions (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
	Y
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 1	269.00%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 2	283.00%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 3	0.001
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 4	0.08
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 5	$0.70
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 6	5
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 7	1.65%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 8	1.80%
Stockholders Deficit Schedule Of Warrants Valuation Assumptions 9	$0

Schedule_of_Warrants_Activity_

Schedule of Warrants Activity (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Stockholders Deficit Schedule Of Warrants Activity 1	$8,266,928
Stockholders Deficit Schedule Of Warrants Activity 2	0.12
Stockholders Deficit Schedule Of Warrants Activity 3	1,114,664
Stockholders Deficit Schedule Of Warrants Activity 4	0.001
Stockholders Deficit Schedule Of Warrants Activity 5	-800,000
Stockholders Deficit Schedule Of Warrants Activity 6	0.001
Stockholders Deficit Schedule Of Warrants Activity 7	$8,581,592
Stockholders Deficit Schedule Of Warrants Activity 8	0.11